¶à²ÊÍø
2024Äê11ÔÂ11-14ÈÕ£¬£¬£¬£¬£¬£¬È«Çò¹æÄ£×î´ó¡¢Ó°ÏìÁ¦×î¹ãµÄÒ½ÁÆÆ÷еչ»áÖ®Ò»MEDICA£¬£¬£¬£¬£¬£¬Ôڵ¹ú¶ÅÈû¶û¶à·òÊ¢·Å×ÝÐС£¡£¡£¡£¡£×÷ΪÖ×ÁöÔçɸºÍÒºÌå»î¼ìÁìÓòµÄÁì¾üÆóÒµ£¬£¬£¬£¬£¬£¬¶à²ÊÍøÉúÎSinglera Genomics£©Ð¯¶àÏîÁ¢Òì²úÆ·ºÍ¼¼Êõ¾ªÑÞÁÁÏ࣬£¬£¬£¬£¬£¬ÓëÀ´×ÔÊÀ½ç¸÷µØµÄÏàÖúͬ°éÉîÈë̽ÌÖÖ×ÁöÔçɸÔçÕïÁìÓòµÄÇ°ÑØÏ£ÍûÓëÏàÖú»úÔµ¡£¡£¡£¡£¡£

ÔÚÕ¹»áÉÏ£¬£¬£¬£¬£¬£¬±¸ÊܹØ×¢µÄÃ÷ÐDzúÆ·ÊÇColonAiQ®£¨ÑªÒº³¦°©¶à»ùÒò¼×»ù»¯Ó«¹âPCRÊÔ¼ÁºÐ£©¡£¡£¡£¡£¡£Õâ¿î²úÆ·²»µ«Äܹ»ÊµÏÖ½áÖ±³¦°©µÄÔçÕ£¬£¬£¬£¬£¬»¹¿ÉÓÃÓÚ³¦°©¸ùÖÎÊõºó¸´·¢µÄÕ¹ÍûÓë¼à²â¡£¡£¡£¡£¡£Ïà±È¹Å°åµÄÓ°Ïñѧ¡¢ÂѰ××éѧ£¬£¬£¬£¬£¬£¬ColonAiQ®Ê¹ÓÃÑ»·Ö×ÁöDNA£¨ctDNA£©¾ßÓÐʵʱ¡¢ÎÞ´´¡¢±ã½ÝµÈÓÅÊÆ¡£¡£¡£¡£¡£»£»£»£»¹¿ÉÓÃ×÷I-IIIÆÚ½áÖ±³¦°©Êõºó¸´·¢Î£º¦Éý¸ßµÄ·Ö×Ó±ê¼ÇÎï[1]¡£¡£¡£¡£¡£
±ðµÄ£¬£¬£¬£¬£¬£¬ÎÒÃÇ»¹´øÀ´ÁËÕë¶Ô¸Îϸ°û°©µÄ¸¨ÖúÕï¶ÏºÍ»¼ÕßÔ¤ºóÆÀ¹ÀµÄ¼×»ù»¯Ð²úÆ·——HepaAiQ®¡£¡£¡£¡£¡£¸Ã²úÆ·ÔÚHCC£¨Hepatocellular Carcinoma£©µÄ¸¨ÖúÕï¶ÏÖÐÌåÏÖ¾«²Ê£¬£¬£¬£¬£¬£¬ÆäÌØÒìÐÔºÍѸËٶȾùÏÔÖø¸ßÓڹŰåµÄAFPºÍDCPÖ¸±ê£¬£¬£¬£¬£¬£¬ÓÐÖúÓÚ¸üÔçµØ·¢Ã÷HCC»¼ÕߵIJ¡Ç飬£¬£¬£¬£¬£¬²¢ÎªÔ¤·ÀÐÔɸ²éºÍÁÆÐ§¼à¿ØÌṩ¸ü±ã½ÝµÄ¼à²â¹¤¾ß[2]¡£¡£¡£¡£¡£
³ýÁ˲úÆ·³öº£Ä£Ê½£¬£¬£¬£¬£¬£¬¶à²ÊÍøÉúÎﻹÓëÀ´×ÔÅ·Ö޺ͱ±ÃÀ¡¢ÀÃÀµÄDZÔÚÏàÖúͬ°éÉîÈë̽ÌÖÁËÁ¢Òì¼¼Êõ³öº£µÄÏàÖúģʽ£¬£¬£¬£¬£¬£¬²¢¸æ¿¢ÆÕ±é¹²Ê¶¡£¡£¡£¡£¡£ÎÒÃǺÜÊÇ×ÔºÀµØ½éÉÜÁËÕë¶ÔÒÈÏÙ°©£¨PDAC£©µÄÔçÆÚɸ²é¼¼Êõ——PDACatch™£¬£¬£¬£¬£¬£¬¿É»ùÓÚ¶þ´ú²âÐòƽ̨ÉÏ×ÊÖú¸ßΣº¦ÒÈÏÙ°©»¼Õ߸üÔçµØ·¢Ã÷Σº¦²¢ÊµÊ±¸ÉÔ¤¡£¡£¡£¡£¡£Õâ¿î²úÆ·ÔøÈÙ»ñÃÀ¹úFDAµÄÍ»ÆÆÐÔÆ÷еÈ϶¨£¨Breakthrough Devices Designation£©¡£¡£¡£¡£¡£

¶à²ÊÍøÉúÎïÔÚMEDICAÕ¹»áÉϵľ«²ÊÌåÏÖ£¬£¬£¬£¬£¬£¬ÕÃÏÔÁËÆóҵǿʢµÄÆ·ÅÆÕкôÁ¦ÒÔ¼°ÁÉÀ«µÄ¹ú¼ÊÊг¡Éú³¤Ô¶¾°¡£¡£¡£¡£¡£³ýÁËÓëÏàÖúͬ°éClinomics EuropeÅäºÏÍÆ³öColonAiQ®¼ì²âЧÀÍÍ⣬£¬£¬£¬£¬£¬Ò²ÔÚ2024 MEDICAÊÕ»ñÁËÀ´×ÔÅ·ÖÞ¡¢ÀÃÀ¡¢Öж«¡¢¶«ÄÏÑÇµÈ¶àµØ¾ÏúÉ̵ÄÏàÖúÒâÔ¸¡£¡£¡£¡£¡£

лл¸÷È˶Զà²ÊÍøÉúÎïµÄ¹Ø×¢ÓëÖ§³Ö£¬£¬£¬£¬£¬£¬ÎÒÃǽ«¼ÌÐøÆð¾¢£¬£¬£¬£¬£¬£¬ÓëÊÀ½ç¸÷µØµÄÏàÖúÆóÒµ¡¢ÙÉÐÐÃÇÅäºÏÍÆ¶¯È«ÈËÀàµÄÖ×ÁöÕï¶Ï·ÀÖÎÊÂÒµ£¬£¬£¬£¬£¬£¬ÎªÈ«ÇòµÄÖ×Áö»¼ÕßÌṩ¸ü׼ȷ¡¢±ã½Ý¡¢¸ßÐԼ۱ȵÄÕï¶Ï½â¾ö¼Æ»®£¡In China, for the world!
²Î¿¼ÎÄÏ×£º
[1] Mo S. Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation[J]. JAMA Oncol. 2023 Jun 1;9(6):770-778.
[2] Guo, D.-Z., et al., Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study. Clinical and Translational Medicine, 2024. 14(5): p. e1652.




